Michele Kutzler

USPTO Granted Patents = 10 (Patent Applications = 1)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 2.9

ph-index = 3

Forward Citations = 78(Granted Patents)

Company Filing History:

9 out of 2,596

University of Pennsylvania

patents

2 out of 87

Inovio Pharmaceuticals, Inc.

patents

1 out of 52

Philadelphia Health and Education Corporation

patents

where one patent can have more than one assignee

Years Active: 2011-2024

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12064481 - Compositions and methods employing adenosine deaminase-1 (ADA-1) as an adjuvant (2024-08-20),

2. 9629907 - Compositions for and methods of inducing mucosal immune responses (2017-04-25),

3. 9446112 - Clostridium difficile DNA vaccine (2016-09-20),

4. 9278128 - Vaccines and immunotherapeutics comprising IL-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same (2016-03-08),

5. 9034313 - Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same (2015-05-19),

6. 8624011 - Vaccines and immunotherapeutics comprising IL-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same (2014-01-07),

7. 8592567 - Vaccines and immunotherapeutics using codon-optimized IL-15 and methods for using the same (2013-11-26),

8. 8178660 - Vaccines and immunotherapeutics using codon optimized IL-15 and methods for using the same (2012-05-15),

9. 8173786 - Nucleic acid sequences encoding and compositions comprising IgE signal peptide and/or IL-15 and methods for using the same (2012-05-08),

10. 8008265 - Vaccines, immunotherapeutics and methods for using the same (2011-08-30),

Title: Michele Kutzler: Innovator in Immunology

Introduction

Michele Kutzler is a prominent inventor based in Souderton, PA (US). She has made significant contributions to the field of immunology, particularly in the development of adjuvants for vaccine enhancement. With a total of 10 patents, her work has been instrumental in advancing medical research and therapeutic applications.

Latest Patents

Kutzler's latest patents include innovative compositions and methods employing adenosine deaminase-1 (ADA-1) as an adjuvant. These patents detail how ADA-1 can enhance the differentiation of T cells, making it a valuable component in vaccine development. Additionally, she has developed compositions for inducing mucosal immune responses, which involve isolated nucleic acid molecules that encode immunogens in combination with various proteins. These methods aim to induce robust immune responses in individuals against specific immunogens.

Career Highlights

Throughout her career, Michele Kutzler has worked with esteemed organizations such as the University of Pennsylvania and Inovio Pharmaceuticals, Inc. Her research has focused on creating effective immunological strategies that can lead to improved vaccine efficacy and patient outcomes.

Collaborations

Kutzler has collaborated with notable colleagues, including David B. Weiner and Andrew Y. Choo. These partnerships have further enriched her research and contributed to the advancement of immunological science.

Conclusion

Michele Kutzler's innovative work in immunology and her numerous patents highlight her significant impact on vaccine development and immune response enhancement. Her contributions continue to shape the future of medical research and therapeutic interventions.

This text is generated by artificial intelligence and may not be accurate.